LANTERN PHARMA INC (LTRN) Top Institutional Shareholders
LANTERN PHARMA INC (LTRN) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $2.83M in LTRN holdings during the latest filing period.
Bios Capital Management, Lp is currently the largest disclosed institutional shareholder of LTRN tracked by InsiderSet, reporting ownership valued at approximately $1.18M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $3.36M, representing an estimated gain of +183.94% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 92% of the total disclosed LTRN value among the investors covered in this analysis. Major shareholders include Bios Capital Management, Lp, Vanguard Capital Management Llc, Cm Management, Llc, and several other long-term asset managers with concentrated positions in LANTERN PHARMA INC (LTRN).
This page ranks the largest institutional LTRN shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
31
Total Reported Value
$2.83M
Largest Holder
Bios Capital Management, Lp
Largest Position
$1.18M
Insider Transactions (90d)
0
Latest Filing Quarter
Q1 2026
New Institutional Positions
37
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Bios Capital Management, Lp | 2.24% | 864,435 | $1,184,276 | $3,362,652 | +$2,178,376 | +183.94% | |
| Vanguard Capital Management Llc | 0.00% | 332,079 | $454,948 | $1,291,787 | +$836,839 | +183.94% | |
| Cm Management, Llc | 0.29% | 250,000 | $342,500 | $972,500 | +$630,000 | +183.94% | |
| Renaissance Technologies LLC | Jim Simons | 0.00% | 116,000 | $158,920 | $451,240 | +$292,320 | +183.94% |
| Geode Capital Management, Llc | 0.00% | 111,646 | $152,984 | $434,303 | +$281,319 | +183.89% | |
| Westside Investment Management, Inc. | 0.01% | 50,050 | $68,571 | $194,695 | +$126,124 | +183.93% | |
| Voss Capital, Lp | 0.00% | 50,000 | $68,500 | $194,500 | +$126,000 | +183.94% | |
| Vanguard Fiduciary Trust Co | 0.00% | 49,607 | $67,962 | $192,971 | +$125,009 | +183.94% | |
| Blackrock, Inc. | 0.00% | 45,267 | $62,016 | $176,089 | +$114,073 | +183.94% | |
| Dimensional Fund Advisors Lp | 0.00% | 38,060 | $52,142 | $148,053 | +$95,911 | +183.94% | |
| Horizon Kinetics Asset Management Llc | 0.00% | 26,373 | $36,131 | $102,591 | +$66,460 | +183.94% | |
| Davenport & Co Llc | 0.00% | 23,814 | $32,625 | $92,636 | +$60,011 | +183.94% | |
| State Street Corp | 0.00% | 23,652 | $32,403 | $92,006 | +$59,603 | +183.94% | |
| Bank Of New York Mellon Corp | 0.00% | 21,301 | $29,182 | $82,861 | +$53,679 | +183.95% | |
| Northern Trust Corp | 0.00% | 15,589 | $21,357 | $60,641 | +$39,284 | +183.94% | |
| Focus Partners Wealth | 0.00% | 15,432 | $21,142 | $60,030 | +$38,888 | +183.94% | |
| Cetera Investment Advisers | 0.00% | 12,228 | $16,752 | $47,567 | +$30,815 | +183.95% | |
| Ubs Group Ag | 0.00% | 10,077 | $13,805 | $39,200 | +$25,395 | +183.95% | |
| Tower Research Capital Llc (Trc) | 0.00% | 3,569 | $4,890 | $13,883 | +$8,993 | +183.91% | |
| Vanguard Global Advisers, Llc | 0.00% | 2,355 | $3,226 | $9,161 | +$5,935 | +183.97% | |
| Sbi Securities Co., Ltd. | 0.00% | 2,144 | $2,937 | $8,340 | +$5,403 | +183.97% | |
| Curio Wealth, Llc | 0.00% | 2,000 | $2,740 | $7,780 | +$5,040 | +183.94% | |
| Wells Fargo & Company/Mn | 0.00% | 1,475 | $2,021 | $5,738 | +$3,717 | +183.91% | |
| Morgan Stanley | 0.00% | 601 | $823 | $2,338 | +$1,515 | +184.07% | |
| Fmr Llc | 0.00% | 500 | $685 | $1,945 | +$1,260 | +183.94% | |
| Northwestern Mutual Wealth Management Co | 0.00% | 500 | $685 | $1,945 | +$1,260 | +183.94% | |
| Osaic Holdings, Inc. | 0.00% | 220 | $301 | $856 | +$555 | +184.32% | |
| Simplex Trading, Llc | 0.00% | 107 | $146 | $416 | +$270 | +185.09% | |
| Citigroup Inc | 0.00% | 45 | $62 | $175 | +$113 | +182.34% | |
| Group One Trading Llc | 0.00% | 23 | $32 | $89 | +$57 | +179.59% | |
| Key Financial Inc | 0.00% | 2 | $3 | $8 | +$5 | +159.33% |
Frequently asked questions about LTRN
Who owns the most LTRN stock?
The largest holders of LTRN are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for LANTERN PHARMA INC (LTRN).
Is LTRN widely held by superinvestors?
Many widely followed stocks like LTRN appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly LTRN is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.